These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. UV and visible light screening by individual sporopollenin exines derived from Lycopodium clavatum (club moss) and Ambrosia trifida (giant ragweed). Atkin SL; Barrier S; Cui Z; Fletcher PD; Mackenzie G; Panel V; Sol V; Zhang X J Photochem Photobiol B; 2011 Mar; 102(3):209-17. PubMed ID: 21232973 [TBL] [Abstract][Full Text] [Related]
3. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults. Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174 [TBL] [Abstract][Full Text] [Related]
4. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F. Siegel LS; Johnson-Winegar AD; Sellin LC Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of severe botulism with 3,4-diaminopyridine]]. Dock M; Ben Ali A; Karras A; Misset B; Garrouste-Orgeas M; Deletie E; Goldstein F; Carlet J Presse Med; 2002 Apr; 31(13):601-2. PubMed ID: 11984982 [TBL] [Abstract][Full Text] [Related]
7. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Adler M; Keller JE; Sheridan RE; Deshpande SS Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741 [TBL] [Abstract][Full Text] [Related]
8. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism. Siegel LS; Price JI Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299 [TBL] [Abstract][Full Text] [Related]
9. 3,4-Diaminopyridine may improve neuromuscular block during botulism. Friggeri A; Marçon F; Marciniak S; Lemaire-Hurtel AS; Seydi A; Ammenouche N; Levrard M; Mahjoub Y; Airapetian N; Tinturier F; Petitjean M; Dupont H Crit Care; 2013 Sep; 17(5):449. PubMed ID: 24007658 [No Abstract] [Full Text] [Related]
10. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps. Adler M; Capacio B; Deshpande SS Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273 [TBL] [Abstract][Full Text] [Related]
11. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS). Sanders DB Ann N Y Acad Sci; 1998 May; 841():811-6. PubMed ID: 9668334 [No Abstract] [Full Text] [Related]
12. Determination of 3,4-diaminopyridine in human plasma by high-performance liquid chromatography. Kamali F; Nicholson E J Pharm Biomed Anal; 1995 May; 13(6):791-4. PubMed ID: 7669834 [No Abstract] [Full Text] [Related]
13. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin. Adler M; Macdonald DA; Sellin LC; Parker GW Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757 [TBL] [Abstract][Full Text] [Related]
14. Cardiac arrest following an iatrogenic 3,4-diaminopyridine intoxication in a patient with Lambert-Eaton myasthenic syndrome. Boerma CE; Rommes JH; van Leeuwen RB; Bakker J J Toxicol Clin Toxicol; 1995; 33(3):249-51. PubMed ID: 7760450 [TBL] [Abstract][Full Text] [Related]
15. Enhanced bioavailability of eicosapentaenoic acid from fish oil after encapsulation within plant spore exines as microcapsules. Wakil A; Mackenzie G; Diego-Taboada A; Bell JG; Atkin SL Lipids; 2010 Jul; 45(7):645-9. PubMed ID: 20495964 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of 3,4-diaminopyridine base in healthy Japanese volunteers. Ishida N; Kobayashi E; Kondo Y; Matsushita R; Komai K Int J Clin Pharmacol Ther; 2015 Aug; 53(8):674-80. PubMed ID: 26152130 [TBL] [Abstract][Full Text] [Related]
17. A platform stratifying a sequestering agent and a pharmacological antagonist as a means to negate botulinum neurotoxicity. Harris TL; Lowery CA; Hixon MS; Janda KD ACS Chem Neurosci; 2014 Aug; 5(8):632-6. PubMed ID: 25000171 [TBL] [Abstract][Full Text] [Related]
18. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis. Polman CH; Bertelsmann FW; de Waal R; van Diemen HA; Uitdehaag BM; van Loenen AC; Koetsier JC Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110 [TBL] [Abstract][Full Text] [Related]
19. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine. Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174 [TBL] [Abstract][Full Text] [Related]